top of page
NEWS
Publications
04.07.2022
The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro. Read more
Press Releases
20.04.2020
CALYXHA announces grant of a European Patent on neurodegenerative diseases. Read more
04.03.2020
CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors. Read more
© Calyxha Biotechnologies GmbH 2022 | All Rights Reserved | Impressum | Privacy policy
bottom of page